Aion Therapeutic ROCE 2024

Aion Therapeutic Aktienanalyse

What does Aion Therapeutic do?

Aion Therapeutic Inc is a Canadian company specializing in the development of medications derived from cannabis and the research of these compounds. The company was founded in 2017 and has been operating on the Toronto Stock Exchange under the ticker symbol AION. The goal of Aion Therapeutic is to advance the development of innovative therapies based on the medical application of cannabinoids. The company focuses on discovering and testing medications that not only have high efficacy but also have a lower risk of side effects. Aion Therapeutic's business model is built on several pillars. This includes research and development of medications based on cannabis compounds such as CBD and THC. The company works closely with experts in the field of science and cannabinoid pharmaceutical production. Another important area is the distribution of cannabis products, such as seeds, oils, extracts, and dried flowers. The company utilizes innovative technologies and processes to improve the quality and effectiveness of these products. In terms of its business activities, Aion Therapeutic can be divided into different areas. One of the most important is the development of medications based on cannabis extract chemotypes that can be used for the prevention and treatment of diseases such as pain, inflammation, chronic conditions, and neurological disorders. The company collaborates closely with leading research institutes and universities worldwide to focus on developing methods that improve the effectiveness and safety of these products. Aion Therapeutic is also active in the manufacturing and marketing of cannabis products. The company offers high-quality cannabinoid extracts from different hemp varieties, specifically tailored to meet the needs of medical users. These products aim to enhance users' well-being and alleviate symptoms of chronic conditions. Another important area of Aion Therapeutic is the application of cannabis-based products in veterinary medicine. The company focuses on developing veterinary medicines specifically designed for pets such as dogs and cats. Similar to the medical application of CBD and THC in humans, the use in veterinary medicine aims to alleviate chronic pain and inflammation or enhance well-being. In summary, Aion Therapeutic is a company specializing in the development of cannabis-based medications and products. With a focus on new technologies and research findings, the company aims to improve the medical application of CBD and THC and establish them as a credible alternative to conventional medications. Aion Therapeutic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Aion Therapeutic's Return on Capital Employed (ROCE)

Aion Therapeutic's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Aion Therapeutic's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Aion Therapeutic's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Aion Therapeutic’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Aion Therapeutic Stock

What is the ROCE (Return on Capital Employed) of Aion Therapeutic this year?

The ROCE of Aion Therapeutic is 0.36 undefined this year.

How has the ROCE (Return on Capital Employed) of Aion Therapeutic developed compared to the previous year?

The ROCE of Aion Therapeutic has increased by -69.32% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Aion Therapeutic?

A high Return on Capital Employed (ROCE) indicates that Aion Therapeutic has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Aion Therapeutic?

A low ROCE (Return on Capital Employed) can indicate that Aion Therapeutic has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Aion Therapeutic impact the company?

An increase in the ROCE of Aion Therapeutic can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Aion Therapeutic affect the company?

A decrease in ROCE of Aion Therapeutic can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Aion Therapeutic?

Some factors that can affect Aion Therapeutic's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Aion Therapeutic so important for investors?

The ROCE of Aion Therapeutic is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Aion Therapeutic take to improve the ROCE?

To improve the ROCE, Aion Therapeutic can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Aion Therapeutic pay?

Over the past 12 months, Aion Therapeutic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aion Therapeutic is expected to pay a dividend of 0 CAD.

What is the dividend yield of Aion Therapeutic?

The current dividend yield of Aion Therapeutic is .

When does Aion Therapeutic pay dividends?

Aion Therapeutic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aion Therapeutic?

Aion Therapeutic paid dividends every year for the past 0 years.

What is the dividend of Aion Therapeutic?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aion Therapeutic located?

Aion Therapeutic is assigned to the '-' sector.

Wann musste ich die Aktien von Aion Therapeutic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aion Therapeutic from 6/30/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.

When did Aion Therapeutic pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Aion Therapeutic in the year 2023?

In the year 2023, Aion Therapeutic distributed 0 CAD as dividends.

In which currency does Aion Therapeutic pay out the dividend?

The dividends of Aion Therapeutic are distributed in CAD.